Talus Bio looks beyond protein structures with new AI drug discovery model
firstwordpharma.comFirstWord Pharma
Talus Bio has developed a new AI model for drug discovery that extends beyond analyzing protein structures. The advancement represents progress in computational approaches to identifying and developing pharmaceutical compounds.
Why it mattersDrug discovery tools that move beyond structure-only analysis could accelerate the identification of viable candidates and reduce development timelines, affecting how AI labs and pharma companies approach therapeutic research.
Read at firstwordpharma.com